Vitamin K Deficiency
Vitamin K
Vitamin K 1
Prothrombin Time
Vitamin K 2
Vitamin K 3
Prothrombin
Elder Nutritional Physiological Phenomena
Antifibrinolytic Agents
Hemorrhagic Disorders
Partial Thromboplastin Time
Vitamin A
1-Carboxyglutamic Acid
Vitamins
Osteocalcin
Intracranial Hemorrhages
Protein Precursors
Potassium Deficiency
Vitamin D
Blood Coagulation Disorders
Vitamin E
Vitamin K Epoxide Reductases
Vitamin A Deficiency
Vitamin B 12
Vitamin D Deficiency
Primary Prevention
Biological Markers
Cathepsin K
Vitamin B 12 Deficiency
Vitamin E Deficiency
Carbon-Carbon Ligases
Cottonseed Oil
Naval Medicine
Encyclopedias as Topic
Morale
Manuscripts, Medical
Prevalence of vitamin K deficiency in cystic fibrosis. (1/146)
BACKGROUND: Patients with cystic fibrosis (CF) are at risk of developing vitamin K deficiency because of pancreatic insufficiency, hepatobiliary disease, or both. OBJECTIVE: Our objective was to determine the prevalence of vitamin K deficiency in unsupplemented patients with CF and to identify risk factors that might be associated with the deficiency. DESIGN: Ninety-eight patients with CF-83 who were pancreatic insufficient (age: 15.2 +/- 10.7 y; range: 0.6-45.8 y), 15 who were pancreatic sufficient (age: 26.2 +/- 11.6 y; range: 6.5-45.3 y), and 62 healthy individuals (age: 16.2 +/- 12. 8 y; range: 1-45 y)-were studied prospectively. None had taken vitamin K supplements. Eight pancreatic-insufficient patients had advanced CF-associated liver disease. Plasma prothrombin in vitamin K absence (PIVKA-II) was measured by immunoassay. All control subjects had PIVKA-II concentrations <3 microg/L. RESULTS: Seventy-eight percent of pancreatic-insufficient patients had PIVKA-II concentrations >/=3 microg/L (22.8 +/- 35.7 microg/L). All patients with CF-associated liver disease had abnormal PIVKA-II concentrations. The mean PIVKA-II concentration of pancreatic-insufficient patients with liver disease was greater than that of those without liver disease (46.6 +/- 65.3 compared with 15. 3 +/- 26.1 microg/L; P < 0.05). Five pancreatic-sufficient patients had mildly elevated PIVKA-II concentrations. Six (7%) pancreatic insufficient patients (3 with CF-associated liver disease) had mildly prolonged prothrombin time but no clinical bleeding. There was no correlation between PIVKA-II concentrations and severity of fat malabsorption or antibiotic use. CONCLUSIONS: Vitamin K deficiency is common in unsupplemented patients with CF and pancreatic insufficiency and routine supplementation should be considered in all of these patients. (+info)Effect of maternal anticonvulsant treatment on neonatal blood coagulation. (2/146)
AIMS: To investigate the impact of maternal anticonvulsant use on the ability of cord blood to coagulate. METHODS: Cord blood prothrombin times were measured, over 15 years in a consecutive series of 137 term babies born to women taking phenobarbitone, phenytoin, and/or carbamazepine while pregnant. The response to parenteral vitamin K was measured in 83 neonates. RESULTS: Only 14 of the 105 babies born to the mothers who had therapeutic anticonvulsant blood concentrations at birth had a prolonged prothrombin time (outside the 95% reference range). None had an overt bleeding tendency. The abnormality was corrected within 2 hours by 1 mg of parenteral vitamin K, but rapid intravenous prophylaxis produced complications in three infants. CONCLUSIONS: A policy of giving vitamin K throughout the last third of pregnancy to all women being treated with anticonvulsants, as recently recommended, is not justified by the available evidence. The belief that there is a distinct, early form of neonatal vitamin K deficiency that is different from, and more dangerous than, the classic form of the disease, is not supported by a review of the published evidence. (+info)Six years' experience of prophylactic oral vitamin K. (3/146)
AIMS: The ability of oral vitamin K to eliminate all risk of vitamin K deficiency bleeding during the first three months of life was studied. METHODS: Babies (n=182,000) in the north of England judged well enough to be offered milk within 12 hours of birth were given 1 mg of phytomenadione (vitamin K(1)) suspended in a medium chain triglyceride oil by mouth at delivery between 1993 and 1998. The parents of those who were breastfed were given a further three doses to give to the baby once every two weeks after discharge. RESULTS: Four breastfed babies developed late vitamin K deficiency bleeding. In two, staff failed to follow policy guidelines, and in two there was undiagnosed alpha(1) antitrypsin deficiency. Audit suggested that 93% of breastfed babies had all four doses, as advised. CONCLUSIONS: An oral product that parents can administer themselves would be popular if licensed, but the total dose offered may need to be more than in this study if babies with undiagnosed liver disease are to be protected. (+info)Warfarin exposure and calcification of the arterial system in the rat. (4/146)
There is evidence from knock-out mice that the extrahepatic vitamin K-dependent protein, matrix gla protein, is necessary to prevent arterial calcification. The aim of this study was to determine if a warfarin treatment regimen in rats, designed to cause extra-hepatic vitamin K deficiency, would also cause arterial calcification. Sprague-Dawley rats were treated from birth for 5-12 weeks with daily doses of warfarin and concurrent vitamin K1. This treatment causes an extrahepatic vitamin K deficiency without affecting the vitamin K-dependent blood clotting factors. At the end of treatment the rats were killed and the vascular system was examined for evidence of calcification. All treated animals showed extensive arterial calcification. The cerebral arteries and the veins and capillaries did not appear to be affected. It is likely that humans on long-term warfarin treatment have extrahepatic vitamin K deficiency and hence they are potentially at increased risk of developing arterial calcification. (+info)Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. (5/146)
BACKGROUND: Vitamin K has been associated with bone mineral density (BMD) and risk of hip fracture. The apolipoprotein (apo) E4 allele (APOE*E4) has been associated with bone fracture through a putative effect on vitamin K transport in blood. OBJECTIVE: The objective was to determine the associations between vitamin K intake, apo E genotype, BMD, and hip fracture in a population-based cohort of elderly men and women. DESIGN: Dietary vitamin K intake was assessed with a food-frequency questionnaire in 335 men and 553 women (average age: 75.2 y) participating in the Framingham Heart Study in 1988-1989. Incidence of hip fractures was recorded from 1988 to 1995. BMD at the hip, spine, and arm was assessed on 2 separate occasions (1988-1989 and 1992-1993). Comparisons between apo E genotype and BMD were made relative to E4 allele status (at least 1 epsilon4 allele compared with no epsilon4 allele). RESULTS: Individuals in the highest quartile of vitamin K intake (median: 254 microg/d) had a significantly lower fully adjusted relative risk (0.35; 95% CI: 0. 13, 0.94) of hip fracture than did those in the lowest quartile of intake (median: 56 microg/d). There were no associations between vitamin K intake and BMD in either men or women. No association was found between the E4 allele and BMD, and there were no significant interactions between the E4 allele and phylloquinone intake and BMD or hip fracture. CONCLUSIONS: Low vitamin K intakes were associated with an increased incidence of hip fractures in this cohort of elderly men and women. Neither low vitamin K intake nor E4 allele status was associated with low BMD. (+info)Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors. (6/146)
A mutation in the gamma-glutamyl carboxylase gene leading to a combined congenital deficiency of all vitamin K-dependent coagulation factors was identified in a Lebanese boy. He is the first offspring of consanguineous parents and was homozygous for a unique point mutation in exon 11, resulting in the conversion of a tryptophan codon (TGG) to a serine codon (TCG) at amino acid residue 501. Oral vitamin K(1) administration resulted in resolution of the clinical symptoms. Screening of several family members on this mutation with an RFLP technique revealed 10 asymptomatic members who were heterozygous for the mutation, confirming the autosomal recessive pattern of inheritance of this disease. In 50 nonrelated normal subjects, the mutation was not found. This is the second time a missense mutation in the gamma-glutamyl carboxylase gene is described that has serious impact on normal hemostasis. (+info)Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? (7/146)
BACKGROUND: A high prevalence of osteoporosis is reported in Crohn's disease. The pathogenesis is not completely understood but is probably multifactorial. Longstanding Crohn's disease is associated with a deficiency of fat soluble vitamins, among them vitamin K. Vitamin K is a cofactor in the carboxylation of osteocalcin, a protein essential for calcium binding to bone. A high level of circulating uncarboxylated osteocalcin is a sensitive marker of vitamin K deficiency. AIMS: To determine serum and bone vitamin K status in patients with Crohn's disease and to elucidate its relationship with bone mineral density. METHODS: Bone mineral density was measured in 32 patients with longstanding Crohn's disease and small bowel involvement, currently in remission, and receiving less than 5 mg of prednisolone daily. Serum levels of vitamins D and K, triglycerides, and total immunoreactive osteocalcin, as well as uncarboxylated osteocalcin ("free" osteocalcin) were determined. The hydroxyapatite binding capacity of osteocalcin was calculated. Data were compared with an age and sex matched control population. RESULTS: Serum vitamin K levels of CD patients were significantly decreased compared with normal controls (p<0.01). "Free" osteocalcin was higher and hydroxyapatite binding capacity of circulating osteocalcin was lower than in matched controls (p<0.05 and p<0.001, respectively), indicating a low bone vitamin K status in Crohn's disease. In patients, an inverse correlation was found between "free" osteocalcin and lumbar spine bone mineral density (r=-0.375, p<0.05) and between "free" osteocalcin and the z score of the lumbar spine (r=-0.381, p<0.05). Multiple linear regression analysis showed that "free" osteocalcin was an independent risk factor for low bone mineral density of the lumbar spine whereas serum vitamin D was not. CONCLUSIONS: The finding that a poor vitamin K status is associated with low bone mineral density in longstanding Crohn's disease may have implications for the prevention and treatment of osteoporosis in this disorder. (+info)A new carboxylation reaction. The vitamin K-dependent incorporation of H-14-CO3- into prothrombin. (8/146)
The bovine plasma zymogen prothrombin contains a number of gamma-carboxyglutamic acid residues which are not found in an abnormal prothrombin produced when cattle are given the vitamin K antagonist dicoumarol. These modified glutamic acid residues appear to be formed post-translationally by a reaction which requires vitamin K. It has been shown that postmitochondrial supernates from vitamin K-deficient rats incorporate added H-14-CO3- minus into microsomal proteins upon the addition of vitamin K. This incorporation is dependent upon the presence of the prothrombin precursor in the microsomal preparations, and upon factors which are present in the postmicrosomal supernatant. Most of the radioactive protein which can be obtained from the microsomal pellet by extraction with 0.25% Triton X-100 has been identified as prothrombin and it can be shown that all of the radioactivity is in the amino-terminal activation fragment of prothrombin. This portion of the protein has previously been shown to contain the gamma-carboxyglutamic acid residues. Hydrolysis of the purified radioactive prothrombin resulted in a loss of 50% of the radioactivity and subsequent chromatography of the amino acid hydrolyzate demonstrated that the remaining radioactivity was entirely in glutamic acid. These results are consistent with the hypothesis that all of the H-14-CO3- minus was incorporated into the carboxyl groups of gamma-carboxyglutamic acid residues. (+info)Vitamin K deficiency is a condition that occurs when the body lacks adequate amounts of Vitamin K, a fat-soluble vitamin essential for blood clotting and bone metabolism. This can lead to an increased risk of excessive bleeding (hemorrhage) and calcification of tissues.
Vitamin K is required for the activation of several proteins involved in blood clotting, known as coagulation factors II, VII, IX, and X. A deficiency in Vitamin K can result in these factors remaining in their inactive forms, leading to impaired blood clotting and an increased risk of bleeding.
Vitamin K deficiency can occur due to several reasons, including malnutrition, malabsorption disorders (such as cystic fibrosis or celiac disease), liver diseases, use of certain medications (such as antibiotics or anticoagulants), and prolonged use of warfarin therapy.
In newborns, Vitamin K deficiency can lead to a serious bleeding disorder known as hemorrhagic disease of the newborn. This is because newborns have low levels of Vitamin K at birth, and their gut bacteria, which are responsible for producing Vitamin K, are not yet fully developed. Therefore, it is recommended that newborns receive a dose of Vitamin K within the first few days of life to prevent this condition.
Symptoms of Vitamin K deficiency can include easy bruising, nosebleeds, bleeding gums, blood in urine or stools, and excessive menstrual bleeding. In severe cases, it can lead to life-threatening hemorrhage. Treatment typically involves administering Vitamin K supplements or injections to replenish the body's levels of this essential nutrient.
Vitamin K Deficiency Bleeding (VKDB) is a condition characterized by an insufficient amount of vitamin K in the body, leading to bleeding complications. It can be further classified into three types:
1. Early onset VKDB: This occurs in the first 24 hours of life and is often seen in infants whose mothers have taken medications that interfere with vitamin K metabolism or who are born prematurely.
2. Classic onset VKDB: This occurs between 2-7 days after birth and is most commonly seen in breastfed infants who have not received vitamin K supplementation at birth.
3. Late onset VKDB: This occurs after the first week of life and can occur up to six months of age. It is often associated with underlying medical conditions that affect vitamin K absorption or metabolism, such as liver disease, cystic fibrosis, or celiac disease.
Symptoms of VKDB may include bleeding from the umbilical cord, gastrointestinal tract, nose, or brain. Treatment typically involves administering vitamin K to stop the bleeding and prevent further complications. Prevention strategies include providing vitamin K supplementation to all newborns at birth.
Vitamin K is a fat-soluble vitamin that plays a crucial role in blood clotting and bone metabolism. It is essential for the production of several proteins involved in blood clotting, including factor II (prothrombin), factor VII, factor IX, and factor X. Additionally, Vitamin K is necessary for the synthesis of osteocalcin, a protein that contributes to bone health by regulating the deposition of calcium in bones.
There are two main forms of Vitamin K: Vitamin K1 (phylloquinone), which is found primarily in green leafy vegetables and some vegetable oils, and Vitamin K2 (menaquinones), which is produced by bacteria in the intestines and is also found in some fermented foods.
Vitamin K deficiency can lead to bleeding disorders such as hemorrhage and excessive bruising. While Vitamin K deficiency is rare in adults, it can occur in newborns who have not yet developed sufficient levels of the vitamin. Therefore, newborns are often given a Vitamin K injection shortly after birth to prevent bleeding problems.
Vitamin K1, also known as phylloquinone, is a type of fat-soluble vitamin K. It is the primary form of Vitamin K found in plants, particularly in green leafy vegetables such as kale, spinach, and collard greens. Vitamin K1 plays a crucial role in blood clotting and helps to prevent excessive bleeding by assisting in the production of several proteins involved in this process. It is also essential for maintaining healthy bones by aiding in the regulation of calcium deposition in bone tissue. A deficiency in Vitamin K1 can lead to bleeding disorders and, in some cases, osteoporosis.
Prothrombin time (PT) is a medical laboratory test that measures the time it takes for blood to clot. It's often used to evaluate the functioning of the extrinsic and common pathways of the coagulation system, which is responsible for blood clotting. Specifically, PT measures how long it takes for prothrombin (a protein produced by the liver) to be converted into thrombin, an enzyme that converts fibrinogen into fibrin and helps form a clot.
Prolonged PT may indicate a bleeding disorder or a deficiency in coagulation factors, such as vitamin K deficiency or the use of anticoagulant medications like warfarin. It's important to note that PT is often reported with an international normalized ratio (INR), which allows for standardization and comparison of results across different laboratories and reagent types.
Vitamin K2, also known as menaquinone, is a fat-soluble vitamin that plays a crucial role in the blood clotting process and bone metabolism. It is one of the two main forms of Vitamin K (the other being Vitamin K1 or phylloquinone), and it is found in animal-based foods and fermented foods.
Vitamin K2 is a collective name for a group of vitamin K compounds characterized by the presence of a long-chain fatty acid attached to the molecule. The most common forms of Vitamin K2 are MK-4 and MK-7, which differ in the length of their side chains.
Vitamin K2 is absorbed more efficiently than Vitamin K1 and has a longer half-life, which means it stays in the body for a longer period. It is stored in various tissues, including bones, where it plays an essential role in maintaining bone health by assisting in the regulation of calcium deposition and helping to prevent the calcification of blood vessels and other soft tissues.
Deficiency in Vitamin K2 is rare but can lead to bleeding disorders and weakened bones. Food sources of Vitamin K2 include animal-based foods such as liver, egg yolks, and fermented dairy products like cheese and natto (a Japanese food made from fermented soybeans). Some studies suggest that supplementing with Vitamin K2 may have benefits for bone health, heart health, and cognitive function. However, more research is needed to confirm these potential benefits.
Hypoprothrombinemia is a medical condition characterized by a decreased level of prothrombin (coagulation factor II) in the blood, which can lead to an increased bleeding tendency. Prothrombin is a protein involved in the coagulation cascade that helps to form blood clots and stop bleeding.
Hypoprothrombinemia can be caused by various factors, including vitamin K deficiency, liver disease, inherited or acquired disorders of prothrombin synthesis, or the use of certain medications such as warfarin. Symptoms may include easy bruising, prolonged bleeding from cuts or injuries, nosebleeds, and in severe cases, internal bleeding. Treatment typically involves addressing the underlying cause and may include vitamin K supplementation, fresh frozen plasma transfusions, or other specific therapies depending on the etiology of the condition.
Vitamin K3 is not typically referred to as a medical definition, but it is a form of Vitamin K. Medically, Vitamins K are coagulation factors that play a crucial role in blood clotting. Specifically, Vitamin K3 is known as Menadione and it is a synthetic version of Vitamin K. Unlike other forms of Vitamin K (K1 and K2), which are found naturally in foods like leafy green vegetables and fermented products, Vitamin K3 is not found in food and must be synthetically produced in a laboratory. It is used in some dietary supplements and animal feed additives. However, the use of Vitamin K3 in human nutrition is limited due to its potential toxicity, especially when given in large doses or to infants.
Prothrombin is a protein present in blood plasma, and it's also known as coagulation factor II. It plays a crucial role in the coagulation cascade, which is a complex series of reactions that leads to the formation of a blood clot.
When an injury occurs, the coagulation cascade is initiated to prevent excessive blood loss. Prothrombin is converted into its active form, thrombin, by another factor called factor Xa in the presence of calcium ions, phospholipids, and factor Va. Thrombin then catalyzes the conversion of fibrinogen into fibrin, forming a stable clot.
Prothrombin levels can be measured through a blood test, which is often used to diagnose or monitor conditions related to bleeding or coagulation disorders, such as liver disease or vitamin K deficiency.
I cannot provide a medical definition for the term "Elder Nutritional Physiological Phenomena" as it is not a widely recognized or established term in the field of medicine or nutrition. It seems to be a very specific and narrow term that may refer to certain age-related changes in nutritional status and physiological functions among older adults. However, I would recommend consulting with a healthcare professional or geriatric specialist for a more accurate and detailed explanation based on the context and specific phenomena being referred to.
Antifibrinolytic agents are a class of medications that inhibit the breakdown of blood clots. They work by blocking the action of enzymes called plasminogen activators, which convert plasminogen to plasmin, the main enzyme responsible for breaking down fibrin, a protein that forms the framework of a blood clot.
By preventing the conversion of plasminogen to plasmin, antifibrinolytic agents help to stabilize existing blood clots and prevent their premature dissolution. These medications are often used in clinical settings where excessive bleeding is a concern, such as during or after surgery, childbirth, or trauma.
Examples of antifibrinolytic agents include tranexamic acid, aminocaproic acid, and epsilon-aminocaproic acid. While these medications can be effective in reducing bleeding, they also carry the risk of thromboembolic events, such as deep vein thrombosis or pulmonary embolism, due to their pro-coagulant effects. Therefore, they should be used with caution and only under the close supervision of a healthcare provider.
Blood coagulation tests, also known as coagulation studies or clotting tests, are a series of medical tests used to evaluate the blood's ability to clot. These tests measure the functioning of various clotting factors and regulatory proteins involved in the coagulation cascade, which is a complex process that leads to the formation of a blood clot to prevent excessive bleeding.
The most commonly performed coagulation tests include:
1. Prothrombin Time (PT): Measures the time it takes for a sample of plasma to clot after the addition of calcium and tissue factor, which activates the extrinsic pathway of coagulation. The PT is reported in seconds and can be converted to an International Normalized Ratio (INR) to monitor anticoagulant therapy.
2. Activated Partial Thromboplastin Time (aPTT): Measures the time it takes for a sample of plasma to clot after the addition of calcium, phospholipid, and a contact activator, which activates the intrinsic pathway of coagulation. The aPTT is reported in seconds and is used to monitor heparin therapy.
3. Thrombin Time (TT): Measures the time it takes for a sample of plasma to clot after the addition of thrombin, which directly converts fibrinogen to fibrin. The TT is reported in seconds and can be used to detect the presence of fibrin degradation products or abnormalities in fibrinogen function.
4. Fibrinogen Level: Measures the amount of fibrinogen, a protein involved in clot formation, present in the blood. The level is reported in grams per liter (g/L) and can be used to assess bleeding risk or the effectiveness of fibrinogen replacement therapy.
5. D-dimer Level: Measures the amount of D-dimer, a protein fragment produced during the breakdown of a blood clot, present in the blood. The level is reported in micrograms per milliliter (µg/mL) and can be used to diagnose or exclude venous thromboembolism (VTE), such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
These tests are important for the diagnosis, management, and monitoring of various bleeding and clotting disorders. They can help identify the underlying cause of abnormal bleeding or clotting, guide appropriate treatment decisions, and monitor the effectiveness of therapy. It is essential to interpret these test results in conjunction with a patient's clinical presentation and medical history.
Hemorrhagic disorders are medical conditions characterized by abnormal bleeding due to impaired blood clotting. This can result from deficiencies in coagulation factors, platelet dysfunction, or the use of medications that interfere with normal clotting processes. Examples include hemophilia, von Willebrand disease, and disseminated intravascular coagulation (DIC). Treatment often involves replacing the missing clotting factor or administering medications to help control bleeding.
Partial Thromboplastin Time (PTT) is a medical laboratory test that measures the time it takes for blood to clot. It's more specifically a measure of the intrinsic and common pathways of the coagulation cascade, which are the series of chemical reactions that lead to the formation of a clot.
The test involves adding a partial thromboplastin reagent (an activator of the intrinsic pathway) and calcium to plasma, and then measuring the time it takes for a fibrin clot to form. This is compared to a control sample, and the ratio of the two times is calculated.
The PTT test is often used to help diagnose bleeding disorders or abnormal blood clotting, such as hemophilia or disseminated intravascular coagulation (DIC). It can also be used to monitor the effectiveness of anticoagulant therapy, such as heparin. Prolonged PTT results may indicate a bleeding disorder or an increased risk of bleeding, while shortened PTT results may indicate a hypercoagulable state and an increased risk of thrombosis.
Medical Definition of Vitamin A:
Vitamin A is a fat-soluble vitamin that is essential for normal vision, immune function, and cell growth. It is also an antioxidant that helps protect the body's cells from damage caused by free radicals. Vitamin A can be found in two main forms: preformed vitamin A, which is found in animal products such as dairy, fish, and meat, particularly liver; and provitamin A carotenoids, which are found in plant-based foods such as fruits, vegetables, and vegetable oils.
The most active form of vitamin A is retinoic acid, which plays a critical role in the development and maintenance of the heart, lungs, kidneys, and other organs. Vitamin A deficiency can lead to night blindness, dry skin, and increased susceptibility to infections. Chronic vitamin A toxicity can cause nausea, dizziness, headaches, coma, and even death.
1-Carboxyglutamic acid, also known as γ-carboxyglutamic acid, is a post-translational modification found on certain blood clotting factors and other calcium-binding proteins. It is formed by the carboxylation of glutamic acid residues in these proteins, which enhances their ability to bind to calcium ions. This modification is essential for the proper functioning of many physiological processes, including blood coagulation, bone metabolism, and wound healing.
Vitamins are organic substances that are essential in small quantities for the normal growth, development, and maintenance of life in humans. They are required for various biochemical functions in the body such as energy production, blood clotting, immune function, and making DNA.
Unlike macronutrients (carbohydrates, proteins, and fats), vitamins do not provide energy but they play a crucial role in energy metabolism. Humans require 13 essential vitamins, which can be divided into two categories: fat-soluble and water-soluble.
Fat-soluble vitamins (A, D, E, and K) are stored in the body's fat tissues and liver, and can stay in the body for a longer period of time. Water-soluble vitamins (B-complex vitamins and vitamin C) are not stored in the body and need to be replenished regularly through diet or supplementation.
Deficiency of vitamins can lead to various health problems, while excessive intake of certain fat-soluble vitamins can also be harmful due to toxicity. Therefore, it is important to maintain a balanced diet that provides all the essential vitamins in adequate amounts.
Osteocalcin is a protein that is produced by osteoblasts, which are the cells responsible for bone formation. It is one of the most abundant non-collagenous proteins found in bones and plays a crucial role in the regulation of bone metabolism. Osteocalcin contains a high affinity for calcium ions, making it essential for the mineralization of the bone matrix.
Once synthesized, osteocalcin is secreted into the extracellular matrix, where it binds to hydroxyapatite crystals, helping to regulate their growth and contributing to the overall strength and integrity of the bones. Osteocalcin also has been found to play a role in other physiological processes outside of bone metabolism, such as modulating insulin sensitivity, energy metabolism, and male fertility.
In summary, osteocalcin is a protein produced by osteoblasts that plays a critical role in bone formation, mineralization, and turnover, and has been implicated in various other physiological processes.
Intracranial hemorrhage (ICH) is a type of stroke caused by bleeding within the brain or its surrounding tissues. It's a serious medical emergency that requires immediate attention and treatment. The bleeding can occur in various locations:
1. Epidural hematoma: Bleeding between the dura mater (the outermost protective covering of the brain) and the skull. This is often caused by trauma, such as a head injury.
2. Subdural hematoma: Bleeding between the dura mater and the brain's surface, which can also be caused by trauma.
3. Subarachnoid hemorrhage: Bleeding in the subarachnoid space, which is filled with cerebrospinal fluid (CSF) and surrounds the brain. This type of ICH is commonly caused by the rupture of an intracranial aneurysm or arteriovenous malformation.
4. Intraparenchymal hemorrhage: Bleeding within the brain tissue itself, which can be caused by hypertension (high blood pressure), amyloid angiopathy, or trauma.
5. Intraventricular hemorrhage: Bleeding into the brain's ventricular system, which contains CSF and communicates with the subarachnoid space. This type of ICH is often seen in premature infants but can also be caused by head trauma or aneurysm rupture in adults.
Symptoms of intracranial hemorrhage may include sudden severe headache, vomiting, altered consciousness, confusion, seizures, weakness, numbness, or paralysis on one side of the body, vision changes, or difficulty speaking or understanding speech. Rapid diagnosis and treatment are crucial to prevent further brain damage and potential long-term disabilities or death.
Hemorrhage is defined in the medical context as an excessive loss of blood from the circulatory system, which can occur due to various reasons such as injury, surgery, or underlying health conditions that affect blood clotting or the integrity of blood vessels. The bleeding may be internal, external, visible, or concealed, and it can vary in severity from minor to life-threatening, depending on the location and extent of the bleeding. Hemorrhage is a serious medical emergency that requires immediate attention and treatment to prevent further blood loss, organ damage, and potential death.
Protein precursors, also known as proproteins or prohormones, are inactive forms of proteins that undergo post-translational modification to become active. These modifications typically include cleavage of the precursor protein by specific enzymes, resulting in the release of the active protein. This process allows for the regulation and control of protein activity within the body. Protein precursors can be found in various biological processes, including the endocrine system where they serve as inactive hormones that can be converted into their active forms when needed.
Potassium deficiency, also known as hypokalemia, is a condition characterized by low levels of potassium (
Vitamin D is a fat-soluble secosteroid that is crucial for the regulation of calcium and phosphate levels in the body, which are essential for maintaining healthy bones and teeth. It can be synthesized by the human body when skin is exposed to ultraviolet-B (UVB) rays from sunlight, or it can be obtained through dietary sources such as fatty fish, fortified dairy products, and supplements. There are two major forms of vitamin D: vitamin D2 (ergocalciferol), which is found in some plants and fungi, and vitamin D3 (cholecalciferol), which is produced in the skin or obtained from animal-derived foods. Both forms need to undergo two hydroxylations in the body to become biologically active as calcitriol (1,25-dihydroxyvitamin D3), the hormonally active form of vitamin D. This activated form exerts its effects by binding to the vitamin D receptor (VDR) found in various tissues, including the small intestine, bone, kidney, and immune cells, thereby influencing numerous physiological processes such as calcium homeostasis, bone metabolism, cell growth, and immune function.
Blood coagulation disorders, also known as bleeding disorders or clotting disorders, refer to a group of medical conditions that affect the body's ability to form blood clots properly. Normally, when a blood vessel is injured, the body's coagulation system works to form a clot to stop the bleeding and promote healing.
In blood coagulation disorders, there can be either an increased tendency to bleed due to problems with the formation of clots (hemorrhagic disorder), or an increased tendency for clots to form inappropriately even without injury, leading to blockages in the blood vessels (thrombotic disorder).
Examples of hemorrhagic disorders include:
1. Hemophilia - a genetic disorder that affects the ability to form clots due to deficiencies in clotting factors VIII or IX.
2. Von Willebrand disease - another genetic disorder caused by a deficiency or abnormality of the von Willebrand factor, which helps platelets stick together to form a clot.
3. Liver diseases - can lead to decreased production of coagulation factors, increasing the risk of bleeding.
4. Disseminated intravascular coagulation (DIC) - a serious condition where clotting and bleeding occur simultaneously due to widespread activation of the coagulation system.
Examples of thrombotic disorders include:
1. Factor V Leiden mutation - a genetic disorder that increases the risk of inappropriate blood clot formation.
2. Antithrombin III deficiency - a genetic disorder that impairs the body's ability to break down clots, increasing the risk of thrombosis.
3. Protein C or S deficiencies - genetic disorders that lead to an increased risk of thrombosis due to impaired regulation of the coagulation system.
4. Antiphospholipid syndrome (APS) - an autoimmune disorder where the body produces antibodies against its own clotting factors, increasing the risk of thrombosis.
Treatment for blood coagulation disorders depends on the specific diagnosis and may include medications to manage bleeding or prevent clots, as well as lifestyle changes and monitoring to reduce the risk of complications.
Medical Definition of Vitamin E:
Vitamin E is a fat-soluble antioxidant that plays a crucial role in protecting your body's cells from damage caused by free radicals, which are unstable molecules produced when your body breaks down food or is exposed to environmental toxins like cigarette smoke and radiation. Vitamin E is also involved in immune function, DNA repair, and other metabolic processes.
It is a collective name for a group of eight fat-soluble compounds that include four tocopherols and four tocotrienols. Alpha-tocopherol is the most biologically active form of vitamin E in humans and is the one most commonly found in supplements.
Vitamin E deficiency is rare but can occur in people with certain genetic disorders or who cannot absorb fat properly. Symptoms of deficiency include nerve and muscle damage, loss of feeling in the arms and legs, muscle weakness, and vision problems.
Food sources of vitamin E include vegetable oils (such as sunflower, safflower, and wheat germ oil), nuts and seeds (like almonds, peanuts, and sunflower seeds), and fortified foods (such as cereals and some fruit juices).
Vitamin K epoxide reductases (VKORs) are enzymes that play a crucial role in the vitamin K cycle, which is essential for the post-translational modification of certain proteins involved in blood coagulation and bone metabolism. Specifically, VKORs reduce vitamin K epoxide back to its active form, vitamin K hydroquinone, allowing it to participate in the carboxylation of these proteins.
The most well-known member of this enzyme family is VKORC1 (Vitamin K Epoxide Reductase Complex Subunit 1), which is the target of the anticoagulant drug warfarin. Warfarin inhibits VKORC1, preventing the reduction of vitamin K epoxide and thereby interfering with the carboxylation of coagulation factors II, VII, IX, and X, as well as proteins C and S. This leads to the production of functionally inactive forms of these proteins and results in the anticoagulant effect of warfarin.
Vitamin A deficiency (VAD) is a condition that occurs when there is a lack of vitamin A in the diet. This essential fat-soluble vitamin plays crucial roles in vision, growth, cell division, reproduction, and immune system regulation.
In its severe form, VAD leads to xerophthalmia, which includes night blindness (nyctalopia) and keratomalacia - a sight-threatening condition characterized by dryness of the conjunctiva and cornea, with eventual ulceration and perforation. Other symptoms of VAD may include Bitot's spots (foamy, triangular, white spots on the conjunctiva), follicular hyperkeratosis (goose bump-like bumps on the skin), and increased susceptibility to infections due to impaired immune function.
Vitamin A deficiency is most prevalent in developing countries where diets are often low in animal source foods and high in plant-based foods with low bioavailability of vitamin A. It primarily affects children aged 6 months to 5 years, pregnant women, and lactating mothers. Prevention strategies include dietary diversification, food fortification, and supplementation programs.
Vitamin B12, also known as cobalamin, is a water-soluble vitamin that plays a crucial role in the synthesis of DNA, formation of red blood cells, and maintenance of the nervous system. It is involved in the metabolism of every cell in the body, particularly affecting DNA regulation and neurological function.
Vitamin B12 is unique among vitamins because it contains a metal ion, cobalt, from which its name is derived. This vitamin can be synthesized only by certain types of bacteria and is not produced by plants or animals. The major sources of vitamin B12 in the human diet include animal-derived foods such as meat, fish, poultry, eggs, and dairy products, as well as fortified plant-based milk alternatives and breakfast cereals.
Deficiency in vitamin B12 can lead to various health issues, including megaloblastic anemia, fatigue, neurological symptoms such as numbness and tingling in the extremities, memory loss, and depression. Since vitamin B12 is not readily available from plant-based sources, vegetarians and vegans are at a higher risk of deficiency and may require supplementation or fortified foods to meet their daily requirements.
A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.
Vitamin D deficiency is a condition characterized by insufficient levels of vitamin D in the body, typically defined as a serum 25-hydroxyvitamin D level below 20 nanograms per milliliter (ng/mL) or 50 nanomoles per liter (nmol/L). Vitamin D is an essential fat-soluble vitamin that plays a crucial role in maintaining healthy bones and teeth by regulating the absorption of calcium and phosphorus. It also has various other functions in the body, including modulation of cell growth, immune function, and neuromuscular activity.
Vitamin D can be obtained through dietary sources such as fatty fish, fortified dairy products, and supplements, but the majority of vitamin D is produced in the skin upon exposure to sunlight. Deficiency can occur due to inadequate dietary intake, insufficient sun exposure, or impaired absorption or metabolism of vitamin D.
Risk factors for vitamin D deficiency include older age, darker skin tone, obesity, malabsorption syndromes, liver or kidney disease, and certain medications. Symptoms of vitamin D deficiency can be subtle and nonspecific, such as fatigue, bone pain, muscle weakness, and mood changes. However, prolonged deficiency can lead to more severe health consequences, including osteoporosis, osteomalacia, and increased risk of fractures.
Primary prevention in a medical context refers to actions taken to prevent the development of a disease or injury before it occurs. This is typically achieved through measures such as public health education, lifestyle modifications, and vaccinations. The goal of primary prevention is to reduce the risk of a disease or injury by addressing its underlying causes. Examples of primary prevention strategies include smoking cessation programs to prevent lung cancer, immunizations to prevent infectious diseases, and safety regulations to prevent accidents and injuries.
A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.
In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:
1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.
It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.
Cathepsin K is a proteolytic enzyme, which belongs to the family of papain-like cysteine proteases. It is primarily produced by osteoclasts, which are specialized cells responsible for bone resorption. Cathepsin K plays a crucial role in the degradation and remodeling of the extracellular matrix, particularly in bone tissue.
This enzyme is capable of breaking down various proteins, including collagen, elastin, and proteoglycans, which are major components of the bone matrix. By doing so, cathepsin K helps osteoclasts to dissolve and remove mineralized and non-mineralized bone matrix during the process of bone resorption.
Apart from its function in bone metabolism, cathepsin K has also been implicated in several pathological conditions, such as osteoporosis, rheumatoid arthritis, and tumor metastasis to bones. Inhibitors of cathepsin K are being investigated as potential therapeutic agents for the treatment of these disorders.
Vitamin B12 deficiency is a condition characterized by insufficient levels of vitamin B12 in the body, leading to impaired production of red blood cells, nerve function damage, and potential neurological complications. Vitamin B12 is an essential nutrient that plays a crucial role in DNA synthesis, fatty acid metabolism, and maintaining the health of the nervous system.
The medical definition of vitamin B12 deficiency includes:
1. Reduced serum or whole blood vitamin B12 concentrations (typically below 200 pg/mL or 145 pmol/L)
2. Presence of clinical symptoms and signs, such as:
* Fatigue, weakness, and lethargy
* Pale skin, shortness of breath, and heart palpitations due to anemia (megaloblastic or macrocytic anemia)
* Neurological symptoms like numbness, tingling, or burning sensations in the hands and feet (peripheral neuropathy), balance problems, confusion, memory loss, and depression
3. Laboratory findings consistent with deficiency, such as:
* Increased mean corpuscular volume (MCV) of red blood cells
* Reduced numbers of red and white blood cells and platelets in severe cases
* Elevated homocysteine and methylmalonic acid levels in the blood due to impaired metabolism
The most common causes of vitamin B12 deficiency include dietary insufficiency (common in vegetarians and vegans), pernicious anemia (an autoimmune condition affecting intrinsic factor production), gastrointestinal disorders (such as celiac disease, Crohn's disease, or gastric bypass surgery), and certain medications that interfere with vitamin B12 absorption.
Untreated vitamin B12 deficiency can lead to severe complications, including irreversible nerve damage, cognitive impairment, and increased risk of cardiovascular diseases. Therefore, prompt diagnosis and treatment are essential for preventing long-term health consequences.
Vitamin E deficiency is a condition that occurs when there is a lack of sufficient vitamin E in the body. Vitamin E is a fat-soluble antioxidant that plays an essential role in maintaining the health of cell membranes, protecting them from damage caused by free radicals. It also helps to support the immune system and promotes healthy blood vessels and nerves.
Vitamin E deficiency can occur due to several reasons, including malnutrition, malabsorption disorders such as cystic fibrosis or celiac disease, premature birth, or genetic defects affecting the alpha-tocopherol transfer protein (alpha-TTP), which is responsible for transporting vitamin E from the liver to other tissues.
Symptoms of vitamin E deficiency may include:
* Neurological problems such as peripheral neuropathy, ataxia (loss of coordination), and muscle weakness
* Retinopathy (damage to the retina) leading to vision loss
* Increased susceptibility to oxidative stress and inflammation
* Impaired immune function
Vitamin E deficiency is rare in healthy individuals who consume a balanced diet, but it can occur in people with certain medical conditions or those who have undergone bariatric surgery. In these cases, supplementation may be necessary to prevent or treat vitamin E deficiency.
Carbon-carbon ligases are a type of enzyme that catalyze the formation of carbon-carbon bonds between two molecules. These enzymes play important roles in various biological processes, including the biosynthesis of natural products and the metabolism of carbohydrates and lipids.
Carbon-carbon ligases can be classified into several categories based on the type of reaction they catalyze. For example, aldolases catalyze the condensation of an aldehyde or ketone with another molecule to form a new carbon-carbon bond and a new carbonyl group. Other examples include the polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs), which are large multienzyme complexes that catalyze the sequential addition of activated carbon units to form complex natural products.
Carbon-carbon ligases are important targets for drug discovery and development, as they play critical roles in the biosynthesis of many disease-relevant molecules. Inhibitors of these enzymes have shown promise as potential therapeutic agents for a variety of diseases, including cancer, infectious diseases, and metabolic disorders.
Cottonseed oil is a type of vegetable oil that is extracted from the seeds of cotton plants. It is commonly used in cooking and food manufacturing due to its mild flavor, high smoke point, and long shelf life. Cottonseed oil is also used in the production of soaps, cosmetics, and industrial lubricants.
In a medical context, cottonseed oil is not typically used as a treatment or therapy. However, it does contain various nutrients and compounds that may have potential health benefits. For example, cottonseed oil is a good source of vitamin E, which has antioxidant properties that can help protect cells from damage. It also contains essential fatty acids like linoleic acid, which are important for maintaining heart health and reducing inflammation.
It's worth noting that cottonseed oil does contain small amounts of gossypol, a naturally occurring toxin found in cotton plants. While the levels of gossypol in cottonseed oil are generally considered safe for human consumption, high doses or long-term exposure can be harmful. Therefore, it's important to consume cottonseed oil in moderation and as part of a balanced diet.
Naval medicine, also known as marine medicine or maritime medicine, is a branch of medicine that deals with the prevention and treatment of diseases and injuries that occur in naval or maritime environments. This can include conditions related to sea travel, such as motion sickness, decompression sickness, and infectious diseases spread through contaminated water or food. It also covers occupational health concerns for naval personnel, including hearing loss from exposure to loud noises, respiratory problems from inhaling fumes, and musculoskeletal injuries from heavy lifting. Additionally, naval medicine may address the unique mental health challenges faced by naval personnel, such as those related to isolation, stress, and combat.
An expedition, in a medical context, is not a term that has a specific or technical meaning. The term "expedition" generally refers to a journey or voyage undertaken with a particular purpose, often to explore or discover new information or territories. In a medical or healthcare setting, an expedition might refer to a research project or mission to provide medical care and assistance in remote or underserved areas. For example, a group of doctors, nurses, and support staff might embark on a medical expedition to provide care and treatment to people living in a rural community with limited access to healthcare services. However, the use of the term "expedition" in this context is not common, and it is more likely that such a journey would be referred to as a "medical mission" or "humanitarian aid trip."
An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.
I'm sorry for any confusion, but "morale" is not a term that has a specific medical definition. Morale generally refers to the overall psychological and emotional well-being or spirit of an individual or group, often in relation to their work, military service, or other collective endeavors. It encompasses factors such as confidence, motivation, and job satisfaction.
However, in a broader sense, morale can be related to mental health and well-being, which are certainly important aspects of medical care and treatment. Factors that contribute to positive morale, like social connections, meaningful activities, and a sense of purpose, can also support overall mental health and resilience.
Medical manuscripts are written documents that describe original research, analysis, or experiences in the field of medicine. These can take various forms such as:
1. Research papers: These report on original studies and include an abstract, introduction, methods, results, discussion, and conclusion sections. They may also include tables, figures, and appendices.
2. Review articles: These provide a comprehensive overview of a specific topic in medicine, summarizing recent developments and findings from multiple sources.
3. Case reports: These describe unusual or interesting medical cases, often serving as educational tools for other healthcare professionals.
4. Clinical trials: These are detailed descriptions of clinical research studies involving human subjects, following a standardized format that includes information on the study's design, methods, results, and conclusions.
5. Systematic reviews and meta-analyses: These involve a rigorous evaluation of all available evidence on a specific research question, using systematic methods to identify, select, and critically appraise relevant studies.
6. Letters to the editor: These are brief communications that may comment on previously published articles or raise new issues for discussion in the medical community.
Medical manuscripts must adhere to strict ethical guidelines and should be written in a clear, concise, and well-organized manner, following the standards set by reputable medical journals. They undergo rigorous peer review before publication to ensure their quality, accuracy, and relevance to the field of medicine.
The term "Arabic Medicine" refers to the medical knowledge and practices that were developed by scholars in the Islamic world, which stretched from Spain to Persia during the Middle Ages (approximately 8th to 15th centuries). This period saw a flourishing of intellectual activity in many fields, including medicine.
Arabic medicine was heavily influenced by ancient Greek and Roman medical texts, particularly those of Galen and Hippocrates. These texts were translated into Arabic and studied by Islamic scholars, who built upon this foundation to make significant contributions of their own.
One of the most famous Arabic physicians was Avicenna (Ibn Sina), who wrote the Canon of Medicine, a comprehensive medical text that was widely used in Europe and the Middle East for centuries. Other notable Arabic physicians include Al-Razi (Rhazes) and Ibn al-Nafis, who made important discoveries in anatomy and physiology.
Arabic medicine encompassed a wide range of topics, including anatomy, pharmacology, surgery, and public health. It emphasized the importance of observation, experimentation, and critical thinking in medical practice, and placed a strong emphasis on the use of rational methods to diagnose and treat illness.
Overall, Arabic medicine played a crucial role in preserving and advancing medical knowledge during the Middle Ages, and its influence can still be seen in modern medical practices today.
I believe there might be a bit of confusion in your question. A "history" in medical terms usually refers to the detailed account of a patient's symptoms, illnesses, and treatments received, which is used by healthcare professionals to understand their health status and provide appropriate care. It is not typically associated with a specific century like the 17th century.
If you are asking for information about the medical practices or significant developments in the field of medicine during the 17th century, I would be happy to provide some insight into that. The 17th century was a time of great advancement in medical knowledge and practice, with several key figures and events shaping the course of medical history.
Some notable developments in medicine during the 17th century include:
1. William Harvey's discovery of the circulation of blood (1628): English physician William Harvey published his groundbreaking work "De Motu Cordis" (On the Motion of the Heart and Blood), which described the circulatory system and the role of the heart in pumping blood throughout the body. This discovery fundamentally changed our understanding of human anatomy and physiology.
2. The development of the microscope (1600s): The invention of the microscope allowed scientists to observe structures that were previously invisible to the naked eye, such as cells, bacteria, and other microorganisms. This technology opened up new avenues of research in anatomy, physiology, and pathology, paving the way for modern medical science.
3. The establishment of the Royal Society (1660): The Royal Society, a prominent scientific organization in the UK, was founded during this century to promote scientific inquiry and share knowledge among its members. Many notable scientists and physicians, including Robert Hooke and Christopher Wren, were part of the society and contributed significantly to the advancement of medical science.
4. The Smallpox Vaccination (1796): Although this occurred near the end of the 18th century, the groundwork for Edward Jenner's smallpox vaccine was laid during the 17th century. Smallpox was a significant public health issue during this time, and Jenner's development of an effective vaccine marked a major milestone in the history of medicine and public health.
5. The work of Sylvius de le Boe (1614-1672): A Dutch physician and scientist, Sylvius de le Boe made significant contributions to our understanding of human anatomy and physiology. He was the first to describe the circulation of blood in the lungs and identified the role of the liver in metabolism.
These are just a few examples of the many advancements that took place during the 17th century, shaping the course of medical history and laying the foundation for modern medicine.